| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
196,581 |
57,136 |
$7.90M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
132,217 |
39,875 |
$981K |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
13,113 |
6,143 |
$150K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,606 |
1,172 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,035 |
367 |
$7K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
62 |
57 |
$626.40 |
| 87641 |
|
60 |
57 |
$192.04 |
| 87631 |
|
35 |
35 |
$119.81 |
| 87581 |
|
51 |
48 |
$109.79 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
50 |
47 |
$80.31 |
| 87541 |
|
51 |
48 |
$80.31 |
| 87640 |
|
54 |
51 |
$80.31 |
| 87486 |
|
51 |
48 |
$80.31 |